1. Home
  2. AMRC vs TRVI Comparison

AMRC vs TRVI Comparison

Compare AMRC & TRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ameresco Inc.

AMRC

Ameresco Inc.

HOLD

Current Price

$27.30

Market Cap

1.6B

ML Signal

HOLD

Logo Trevi Therapeutics Inc.

TRVI

Trevi Therapeutics Inc.

HOLD

Current Price

$13.04

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AMRC
TRVI
Founded
2000
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2010
2019

Fundamental Metrics

Financial Performance
Metric
AMRC
TRVI
Price
$27.30
$13.04
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
8
12
Target Price
$39.25
$20.38
AVG Volume (30 Days)
456.1K
1.2M
Earning Date
06-02-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.49
N/A
Revenue
$1,769,928,000.00
N/A
Revenue This Year
$10.29
N/A
Revenue Next Year
$10.42
N/A
P/E Ratio
$57.65
N/A
Revenue Growth
28.76
N/A
52 Week Low
$8.49
$4.24
52 Week High
$44.93
$14.39

Technical Indicators

Market Signals
Indicator
AMRC
TRVI
Relative Strength Index (RSI) 34.98 68.58
Support Level $26.29 $10.04
Resistance Level $31.12 $14.39
Average True Range (ATR) 1.90 0.69
MACD -0.65 0.26
Stochastic Oscillator 12.21 87.26

Price Performance

Historical Comparison
AMRC
TRVI

About AMRC Ameresco Inc.

Ameresco Inc provides energy efficiency solutions for facilities in North America and Europe. It focuses on projects that reduce energy, also focuses on the operations and maintenance costs of governmental, educational, utility, healthcare, and other institutional, commercial, and industrial entities facilities. Ameresco distributes solar energy products and systems, such as PV panels, solar regulators, solar charge controllers, inverters, solar-powered lighting systems, solar-powered water pumps, solar panel mounting hardware, and other system components. The company's segment includes U.S. Regions; U.S. Federal; Canada; Alternative Fuels; Non-Solar DG and All Other. It derives a majority of its revenue from the U.S. Regions segment.

About TRVI Trevi Therapeutics Inc.

Trevi Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the development and commercialization of the investigational therapy Haduvio (oral nalbuphine ER) for the treatment of chronic cough in adults with idiopathic pulmonary fibrosis, or IPF, and other chronic cough indications, and for the treatment of prurigo nodularis. Haduvio is an oral extended-release formulation of nalbuphine.

Share on Social Networks: